J&J beats quarterly sales and profit estimates on cancer drug sales

Johnson & Johnson reported fourth-quarter sales and profit above Wall Street estimates on Wednesday, driven by strong sales of its cancer treatments.

Leave a Reply

Your email address will not be published. Required fields are marked *